Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Upregulation of Antioxidant Genes in Antimony-Resistant Leishmania Tropica Clinical Isolates Publisher Pubmed



Ahmadpour M1, 2 ; Valashani HT1, 2 ; Naddaf SR1 ; Mohebali M3 ; Hajjaran H3 ; Ghazineghad B1 ; Khosravi R3 ; Mousavi P4 ; Kazemirad E1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran
  2. 2. Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran
  3. 3. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Molecular Biology Reports Published:2025


Abstract

Background: Increasing resistance to antimonial drugs has become a significant challenge in effective treatment in endemic regions of leishmaniasis. Antioxidant defense plays a crucial role in antimony resistance by combating antimonial-induced oxidative stress. Accordingly, we investigated the transcript levels of some antioxidant genes in antimony-sensitive and resistant clinical Leishmania tropica isolates. Methods: In the current study, 22 Leishmania tropica isolates from ACL patients who presented responsive or unresponsive to antimony were examined. The susceptibility of parasites against SbV and hydrogen peroxide (H2O2) was analyzed. We evaluated the transcript levels of five genes, including cytosolic and mitochondrial tryparedoxin (cTXN, mTXN), cytosolic and mitochondrial tryparedoxin peroxidase (cTXNPx, mTXNPx), and ascorbate peroxidase (APX) in antimony-sensitive and resistant L. tropica clinical isolates. Results: The in-vitro susceptibility to SbV in intracellular amastigotes revealed 3.82 times higher IC50 in resistant isolates compared to sensitive ones. The IC50 toward H2O2 in resistant isolates was 1.6 times higher than in sensitive ones, positively correlated with SbV IC50 values. The average transcript expression level of cTXNPx, mTXNPx, cTXN, and APX genes significantly increased in resistant isolates by 2.51, 1.69, 2.41, and 2.12-fold compared to sensitive ones. The highest correlation coefficient between the gene expression and SbV IC50 values belonged to the cTXNPx, cTXN, APX, mTXN, and mTXNPx genes, respectively. The average transcript expression level of cytosolic TXN and TXNPx in resistant L. tropica isolates was higher than its mitochondrial counterpart. Conclusions: The data presented here revealed a phenotypic heterogeneity in antioxidant gene expression among L. tropica clinical isolates. Overall, the upregulation of genes involved in antioxidant defense could probably contribute to natural antimony resistance in L. tropica clinical isolates. © The Author(s), under exclusive licence to Springer Nature B.V. 2025.
Related Docs
View other Related Docs
1. Insights Into the Trypanothione System in Antimony-Resistant and Sensitive Leishmania Tropica Clinical Isolates, Acta Tropica (2024)
2. Identification of Cβs and Odc Antimony Resistance Markers in Anthroponotic Cutaneous Leishmaniasis Field Isolates by Gene Expression Profiling, Parasite Epidemiology and Control (2025)
3. Overexpression of Iron Super Oxide Dismutases A/B Genes Are Associated With Antimony Resistance of Leishmania Tropica Clinical Isolates, Iranian Journal of Parasitology (2022)
4. Gene Expression Analysis of Antimony Resistance in Leishmania Tropica Using Quantitative Real-Time Pcr Focused on Genes Involved in Trypanothione Metabolism and Drug Transport, Archives of Dermatological Research (2019)
5. Involvement of Tryparedoxin Peroxidase (Tryp) and Trypanothione Reductase (Tryr) in Antimony Unresponsive of Leishmania Tropica Clinical Isolates of Iran, Acta Tropica (2022)
6. The Role of Atp-Binding Cassette Transporter Genes Expression in Treatment Failure Cutaneous Leishmaniasis, AMB Express (2022)
7. Comparative Mitochondrial Proteomics of Leishmania Tropica Clinical Isolates Resistant and Sensitive to Meglumine Antimoniate, Parasitology Research (2020)
8. Review of the Prevalence and Causes of Antimony Compounds Resistance in Different Societies: Review Article, Tehran University Medical Journal (2017)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (30)
Homa Hajjaran (20)
Other Related Docs
9. Proteomic-Based Studies on Leishmania, Journal of Mazandaran University of Medical Sciences (2018)
10. Expression Analysis of Activated Protein Kinase C Gene (Lack1) in Antimony Sensitive and Resistant Leishmania Tropica Clinical Isolates Using Real-Time Rt-Pcr, International Journal of Dermatology (2016)
11. An Overview of Leishmanization Experience: A Successful Control Measure and a Tool to Evaluate Candidate Vaccines, Acta Tropica (2019)
12. Comparative Proteomic Profiling of Leishmania Tropica: Investigation of a Case Infected With Simultaneous Cutaneous and Viscerotropic Leishmaniasis by 2-Dimentional Electrophoresis and Mass Spectrometry, Iranian Journal of Parasitology (2015)
13. Photodynamic Therapy Using Toluidine Blue O (Tbo) Dye As a Photosensitizer Against Leishmania Major, Iranian Journal of Public Health (2021)
14. Comparative Expression Profile Analysis of Apoptosis-Related Mirna and Its Target Gene in Leishmania Major Infected Macrophages, Iranian Journal of Parasitology (2020)
15. Correlation Between Clinical Responses With the Drug-Susceptibility of Parasites in Iranian Cutaneous Leishmaniasis Caused by Leishmania Major, Tropical Biomedicine (2017)
16. The Geographical Distribution of Human Cutaneous and Visceral Leishmania Species Identified by Molecular Methods in Iran: A Systematic Review With Meta-Analysis, Frontiers in Public Health (2021)
17. Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania Major to Glucantime® by 2-Dimensional Electrophoresis, Iranian Journal of Parasitology (2015)
18. Quantitative Proteomic Analysis Reveals Differentially Expressed Proteins in Leishmania Major Metacyclogenesis, Microbial Pathogenesis (2020)
19. Expression Analysis of Viscerotropic Leishmaniasis Gene in Leishmania Species by Real-Time Rt-Pcr, Acta Parasitologica (2016)
20. Treatment Failure in Cutaneous Leishmaniasis Patients Referred to the School of Public Health, Tehran University of Medical Sciences During 2008-2017, Journal of Arthropod-Borne Diseases (2020)
21. Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis, Journal of Epidemiology and Global Health (2024)
22. Antimonial Treatment Failure Rate in Patients With Cutaneous Leishmaniasis, Tehran University Medical Journal (2018)
23. Potent Antileishmanial Activity of Chitosan Against Iranian Strain of Leishmania Major (Mrho/Ir/75/Er): In Vitro and in Vivo Assay, Journal of Vector Borne Diseases (2018)
24. Niosomal Formulation of Amphotericin B Alone and in Combination With Glucantime: In Vitro and in Vivo Leishmanicidal Effects, Biomedicine and Pharmacotherapy (2019)
25. Comparison of P27 Gene Expression of Promastigote and Amastigote Forms of Leishmania Major (Mrho/Ir/75/Er) by Real-Time Rt-Pcr, Iranian Journal of Parasitology (2018)
26. Development of a Topical Liposomal Formulation of Amphotericin B for the Treatment of Cutaneous Leishmaniasis, International Journal for Parasitology: Drugs and Drug Resistance (2019)
27. Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model As a Candidate for Treatment of Cutaneous Leishmaniasis, Journal of Arthropod-Borne Diseases (2018)
28. Comparative Analysis Between Four Model Nanoformulations of Amphotericin B-Chitosan, Amphotericin B-Dendrimer, Betulinic Acid-Chitosan and Betulinic Acid-Dendrimer for Treatment of Leishmania Major: Real-Time Pcr Assay Plus, International Journal of Nanomedicine (2019)
29. Molecular Identification of Cutaneous Leishmaniasis Species in the Northcentral Iranian Province of Alborz: Is There a New Focus on Cutaneous Leishmaniasis in the Province?, Iranian Journal of Parasitology (2023)
30. Economic Burden of Cutaneous and Visceral Lishmaniasis in Iran in 2013, Iranian Journal of Epidemiology (2017)
31. The Role of Glcnac-Pi-De-N-Acetylase Gene by Gene Knockout Through Homologous Recombination and Its Consequences on Survival, Growth and Infectivity of Leishmania Major in in Vitro and in Vivo Conditions, Acta Tropica (2016)
32. Assessment of the Antileishmanial Activity of Diallyl Sulfide Combined With Meglumine Antimoniate on Leishmania Major: Molecular Docking, in Vitro, and Animal Model, PLoS ONE (2024)
33. In Vitro and in Vivo Therapeutic Potentials of 6-Gingerol in Combination With Amphotericin B for Treatment of Leishmania Major Infection: Powerful Synergistic and Multifunctional Effects, International Immunopharmacology (2021)
34. Expression Analysis of Centrin Gene in Promastigote and Amastigote Forms of Leishmania Infantum Iranian Isolates: A Promising Target for Live Attenuated Vaccine Development Against Canine Leishmaniasis, BMC Veterinary Research (2021)
35. Visceral Leishmaniasis in Iran: An Update on Epidemiological Features From 2013 to 2022, Iranian Journal of Parasitology (2023)
36. Transforming Growth Factor Beta-Induced Factor 2-Linked X (Tgif2lx) Regulates Two Morphogenesis Genes, Nir1 and Nir2 in Human Colorectal, Acta Medica Iranica (2016)
37. A Comparison Between the Effects of Glucantime, Topical Trichloroacetic Acid 50% Plus Glucantime, and Fractional Carbon Dioxide Laser Plus Glucantime on Cutaneous Leishmaniasis Lesions, Dermatology Research and Practice (2016)
38. Study on Knowledge, Attitude and Practice of Health Workers of East Azerbaijan, Ilam and Khorasan Razavi Provinces About Leishmaniasis During 2015-2016: A Comparative Study Before and After Intervention, Archives of Clinical Infectious Diseases (2019)
39. Leishmanicidal Potentials of Gossypium Hirsutum Extract and Its Fractions on Leishmania Major in a Murine Model: Parasite Burden, Gene Expression, and Histopathological Profile, Journal of Medical Microbiology (2021)
40. The Effects of Leishmania Rna Virus 2 (Lrv2) on the Virulence Factors of L. Major and Pro-Inflammatory Biomarkers: An in Vitro Study on Human Monocyte Cell Line (Thp-1), BMC Microbiology (2023)
41. Anti Leishmania Activity of Lucilia Sericata and Calliphora Vicina Maggots in Laboratory Models, Experimental Parasitology (2016)
42. Leishmania Rna Virus 2 (Lrv2) Exacerbates Dermal Lesions Caused by Leishmania Major and Comparatively Unresponsive to Meglumine Antimoniate Treatment, Experimental Parasitology (2022)
43. Epidemiological Study of Cutaneous Leishmaniasis in Some Iraqi Provinces, Journal of Men's Health (2018)
44. A Novel Strategy for Enhance Potentiation of Meglumine Antimoniate Against Leishmania Major in Vitro, Iranian Journal of Parasitology (2019)
45. Salivary Gland Antigens of Laboratory-Bred Phlebotomus Sergenti and Their Immunogenicity in Human Volunteers in Laboratory Condition, Asian Pacific Journal of Tropical Medicine (2020)
46. Downregulation of Gjb2 and Slc26a4 Genes Induced by Noise Exposure Is Associated With Cochlear Damage, Molecular Biology Reports (2022)
47. Associated-Risk Determinants for Anthroponotic Cutaneous Leishmaniasis Treated With Meglumine Antimoniate: A Cohort Study in Iran, PLoS Neglected Tropical Diseases (2019)
48. Immunotherapeutic Effects of Glycyrrhiza Glabra and Glycyrrhizic Acid on Leishmania Major-Infection Balb/C Mice, Parasite Immunology (2022)
49. Sambucus Ebulus Extract Stimulates Cellular Responses in Cutaneous Leishmaniasis, Parasite Immunology (2019)
50. Treatment of Resistant Visceral Leishmaniasis With Interferon Gamma in Combination With Liposomal Amphotericin B and Allopurinol, Parasitology International (2019)